US2015198607A1PendingUtilityA1
Algorithms for calibrating an analyte sensor
Est. expiryFeb 6, 2027(~0.5 yrs left)· nominal 20-yr term from priority
G01N 21/6486G01N 33/66A61B 5/1455G01N 2201/062A61B 5/14532G01N 2021/6432G01N 31/22G01N 21/6428G01N 33/582G01N 2201/127G01N 33/52
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are embodiments that relate to algorithms and methods for calibrating an analyte sensor, and more particularly, to algorithms for calibrating an optical glucose sensor comprising an equilibrium fluorescent chemical indicator system. In particular, a method of detecting an analyte concentration is disclosed where a modified Michaelis-Menten equation comprising Michaelis-Menten parameters is used to characterize the signal generated by the analyte sensor.
Claims
exact text as granted — not AI-modified1 - 15 . (canceled)
16 . A measurement device for estimating glucose concentration comprising:
an optical sensor including a non-enzymatic, equilibrium fluorescence chemical indicator system disposed along a distal region of an optical fiber, the chemical indicator system including a fluorophore operably coupled to a glucose binding moiety, wherein the fluorophore is configured to generate a fluorescent emission signal upon excitation with light, and wherein glucose binding to the glucose binding moiety causes a change in the fluorescent emission signal related to the glucose concentration in the physiologic fluid; and a processing module configured to transform the fluorescent emission signal intensity into a glucose concentration value using the equation:
[ G]=c *( I−a )/( a+b−I ), wherein
[G] is the glucose concentration,
I is the fluorescent emission signal intensity,
a is the value of the fluorescent emission signal intensity in the absence of glucose,
b is the value of the asymptotic signal intensity at infinite glucose concentration, minus the fluorescent signal intensity in the absence of glucose (a), and
c is the value of the glucose concentration at which the fluorescent signal intensity is one-half the difference between the asymptotic value (b) and the background (a).
17 . The measurement device of claim 16 , wherein the optical sensor further includes:
at least one light source configured to generate light; and at least one detector configured to detect the fluorescent emission signal intensity and generate a signal indicative of the glucose concentration.
18 . The measurement device of claim 16 , wherein the indicator system further includes an immobilizing matrix configured to prevent the fluorophore and/or the glucose binding moiety from diffusing out of the sensor.
19 . The measurement device of claim 16 , wherein the fluorophore is HPTS-triCys-MA.
20 . The measurement device of claim 16 , wherein the glucose binding moiety comprises boronic acid.
21 . The measurement device of claim 16 , wherein a, b and c are from a set of ex vivo measurements of the fluorescent emission signal(s) generated using one or more solutions of known glucose concentrations.
22 . The measurement device of claim 16 , wherein a, b and c are determined during a factory calibration of the chemical indicator system.
23 . The measurement device of claim 16 , further comprising a calibration system configured to perform an ex vivo calibration, the calibration system comprising:
one or more solutions with known glucose concentrations.
24 . The measurement device of claim 16 , the calibration system further comprising:
a temperature controlling module configured to control the temperature of the one or more solutions with known glucose concentrations.
25 . The measurement device of claim 16 , wherein the processing module is configured to correct a, b and c by multiplying a, b, and c by a correction factor calculated by comparing an in vitro or in vivo measured signal with a predicted signal calculated by the analyte concentration measured independently of the measurement device.
26 . The measurement device of claim 16 , wherein the physiologic solution is blood.
27 . The measurement device of claim 16 , wherein the optical sensor includes a mirror and a thermistor each placed at the distal end of the optical fiber.
28 . A measurement device for estimating glucose concentration comprising:
an optical sensor including a non-enzymatic, equilibrium fluorescence chemical indicator system disposed along a distal region of an optical fiber, the chemical indicator system including a fluorophore operably coupled to a glucose binding moiety, wherein the fluorophore is configured to generate a fluorescent emission signal upon excitation with light, and wherein glucose binding to the glucose binding moiety causes a change in the fluorescent emission signal related to the glucose concentration in the physiologic fluid; a detector operable to measure a fluorescent emission signal intensity generated by the fluorophore; and a processing module configured to transform the fluorescent emission signal intensity into a glucose concentration value based on a value of the fluorescent emission signal intensity in the absence of glucose, a value of the asymptotic intensity of the fluorescent emission signal at infinite glucose, and a value of the glucose concentration at which the fluorescent emission intensity is one-half the difference between the fluorescent emission signal intensity in the absence of glucose and the asymptotic intensity of the fluorescent emission signal at infinite glucose, using the equation:
[ G]=c *( I−a )/( a+b−I ), wherein
[G] is the glucose concentration,
I is the fluorescent emission signal intensity,
a is the value of the fluorescent emission signal intensity in the absence of glucose,
b is the value of the asymptotic signal intensity at infinite glucose concentration, minus the fluorescent signal intensity in the absence of glucose (a), and
c is the value of the glucose concentration at which the fluorescent signal intensity is one-half the difference between the asymptotic value (b) and the background (a).
29 . A measurement device for estimating glucose concentration comprising:
an optical sensor including a non-enzymatic, equilibrium fluorescence chemical indicator system disposed along a distal region of an optical fiber, the chemical indicator system including a fluorophore operably coupled to a glucose binding moiety, wherein the fluorophore is configured to generate a fluorescent emission signal upon excitation with light, and wherein glucose binding to the glucose binding moiety causes a change in the fluorescent emission signal related to the glucose concentration in the physiologic fluid; and a processing module configured to transform the fluorescent emission signal intensity into a glucose concentration value using the equation:
F=F min +F max K[X ]/(1+ K[X ]), wherein
[X] is the glucose concentration,
F is the fluorescent emission signal intensity,
F min is the fluorescent emission signal intensity in the absence of glucose,
F max is the maximum fluorescent emission signal intensity when the system is saturated with glucose, and
K is the binding affinity of the glucose binding moiety of the chemical indicator system.Join the waitlist — get patent alerts
Track US2015198607A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.